Study of Durvalumab + Tremelimumab in NSCLC Patients After Adjuvant Treatment
Clinical trial NCT04625699 · WITHDRAWN
Trial details
- NCT number
- NCT04625699
- Sponsor
- Catherine Shu
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-01
- Primary completion
- 2023-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.